Glycemic Response to an Innovative Cookie to Promote Human Health

KU Leuven55 enrolled

Overview

The aim of this study is to investigate whether using a coarse wheat fraction in wire-cut cookie making induces a lower glycemic response in healthy subjects compared to wheat flour.

This study has a double-blind, randomized, cross-over design. During each of the two study visits, healthy participants will consume a standard portion of cookies. One cookie formulation will present a large amount of coarse wheat fraction, while the other formulation will include only wheat flour and will serve as a control. Blood glucose measurements will be taken postprandially at regular time points. Gastric emptying rate and oral processing behavior will be also object of study.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

DOUBLE

Enrollment

Conditions

Postprandial Glycemic Responses

Interventions

Wire-cut cookieDIETARY_SUPPLEMENT

Investigation of the impact of wheat particle size on the postprandial glycemic response, gastric emptying and oral processing behavior after consumption of wire-cut cookies.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Body mass index (BMI) range 18.5 - 25.0 kg/m2 at screening visit * Fasting whole blood glucose values \< 6.3 mmol/L * Regular diet with 3 meals a day (at least 5 times a week) * Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigators on the basis of medical history * Willingness to maintain habitual diet, physical activity pattern, and body weight throughout the trial * Willingness to abstain from alcohol consumption and to avoid vigorous physical activity for 24 h prior to study visits * Adequate level of understanding spoken and written English * Willingness to report lifestyle factors such as level of physical activity and perceived psychological stress * Willingness to provide informed consent to participate in the study Exclusion Criteria: * Failure to meet any one of the inclusion criteria * Recent participation in any clinical trial (\< 90 days) * Pregnant or lactating or wishing to become pregnant in the period of the study * Known history of AIDS, hepatitis, diabetes mellitus (Type I and II), cardiovascular disease, any pathology (or recent surgical event) of the gastrointestinal system or any current metabolic or endocrine disease * Alcohol consumption of \> 14 standard drinks for women and \> 21 standard drinks for men per week * Currently smoking (have smoked in the last 28 days) or willingness to smoke during the study period * Celiac disease or gluten intolerance * Use of medications known to influence carbohydrate metabolism, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids the last 4 weeks before the screening visit * Use of antibiotics during the last three months * Reported slimming or medically prescribed diet * Unwillingness or inability to comply with the experimental procedures and to follow the safety guidelines

Locations (1)

KU Leuven/UZ Leuven

Leuven, Vlaams-Brabant, Belgium

Outcomes

Primary Outcomes

Glucose response

Incremental area under the curve of blood glucose concentration (mM) after wheat-based wire-cut cookie consumption, measured through blood samples collected via finger-prick before eating (i.e. 10 and 5 minutes before ingestion) and at respective time points after consumption of test meal (i.e. 10, 20, 30, 45, 60, 75, 90, 120, 150 and 180 minutes).

Time frame: 10, 5 minute before and 10, 20, 30, 45, 60, 75, 90, 120, 150 and 180 minutes after consumption of test meal, both test day 1 and 2

Secondary Outcomes

Peak rise of blood glucose

Difference between the highest postprandial blood glucose concentration and the baseline (expressed in mM), measured through blood samples collected via finger-prick before eating (i.e. 10 and 5 minutes before ingestion) and at respective time points after consumption of test meal (i.e. 10, 20, 30, 45, 60, 75, 90, 120, 150 and 180 minutes).

Time frame: 10, 5 minute before and 10, 20, 30, 45, 60, 75, 90, 120, 150 and 180 minutes after consumption of test meal, both test day 1 and 2

Gastric emptying rate

Measured through 13C-octanoic acid breath samples collected before eating (i.e. 0 minute) and at respective time points after consumption of test meal (i.e. 10, 20, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180 minutes).

Time frame: 0, 10, 20, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180 minutes after consumption of test meal, on test day 1

Gastric emptying rate

Time frame: 0, 10, 20, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180 minutes after consumption of test meal, on test day 2

Oral processing behavior (exposure time)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.